Patentable/Patents/US-10309974
US-10309974

Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease

PublishedJune 4, 2019
Assigneenot available in USPTO data we have
Inventorsnot available in USPTO data we have
Technical Abstract

Disclosed herein are methods for diagnosing cardiovascular disease. The methods comprise detection of citrullinated proteins and/or citrullinated peptides. Also disclosed herein are methods, compositions, and kits for diagnosing and/or treating cardiovascular disease.

Patent Claims

Legal claims defining the scope of protection, as filed with the USPTO.

Claim text for this patent isn't available yet.

Classification Codes (CPC)

Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.

G01NC12Q
Patent Metadata

Filing Date

November 15, 2017

Publication Date

June 4, 2019

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Browse All PatentsTry Prior Art Search
Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease” (US-10309974). https://patentable.app/patents/US-10309974

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.